Eptinezumab structure
|
Common Name | Eptinezumab | ||
---|---|---|---|---|
CAS Number | 1644539-04-7 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EptinezumabEptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
Name | Eptinezumab |
---|
Description | Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
---|---|
Related Catalog | |
References |
[1]. Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739. |
No Any Chemical & Physical Properties |